Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer
書誌事項
- 公開日
- 2004-12
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.3816/cbc.2004.n.040
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Clinical Breast Cancer
-
Clinical Breast Cancer 5 (5), 348-352, 2004-12
Elsevier BV